TF and neoplasm: Recently, we reported on the anti-tumor effects of RabMab1, our monoclonal antibody that binds the alternatively spliced isoform of human tissue factor (asTF), in a setting of orthotopic co-implantation with TF-expressing human PDAC cells (3).